Billionaire Profile

Global Rank

#493

Image: Public domain | via Wikimedia Commons

Viktor Kharitonin

CEO, Pharmstandard

Real-Time Net Worth

$7.5B

As of December 2025

Age

Source

Pharmaceuticals

Industry

healthcare

Citizenship

Biography

Viktor Kharitonin is a prominent Russian billionaire with a net worth of $7.5 billion as of December 5, 2025. His wealth primarily stems from the pharmaceutical industry, specifically through his company Pharmstandard, which he co-founded with Roman Abramovich in 2003. Kharitonin's career highlights include building Pharmstandard into a leading pharmaceutical company in Russia, listing it on the London Stock Exchange in 2008, and later taking it private in 2016. He has expanded his portfolio by acquiring the TSS group and owning the Nürburgring race track in Germany. Kharitonin, a graduate of Novosibirsk State University, is known for his close ties to Russian political figures.

Wealth Over Time

Portfolio Holdings

Pharmstandard

In-Depth Profile

Early Life

Viktor Kharitonin was born in Novosibirsk, Russia, on November 20, 1972. Little information is available about his early life. He graduated from Novosibirsk State University with a Master of Science degree.

Rise to Success

Kharitonin's career began in the early 1990s during a period of significant economic and political change in Russia. He saw an opportunity in the pharmaceutical industry and co-founded Pharmstandard with Roman Abramovich in 2003. The company quickly became a leading producer of pharmaceutical products in Russia. In 2008, Pharmstandard was listed on the London Stock Exchange. Kharitonin, along with his partner Egor Kulkov, later brought the company back into private hands in 2016.

Key Business Strategies

Kharitonin's key business strategies include focusing on quality and affordability in the pharmaceutical market. He expanded his business portfolio by acquiring the TSS group, an equipment manufacturing firm in 2021. Additionally, he owns the Nürburgring race track in Germany.

Philanthropy

Kharitonin is known for his philanthropic efforts, particularly in healthcare, education, and community development. He has funded programs aimed at addressing health issues and supported healthcare infrastructure development.

Career Milestones

2003

Co-founded Pharmstandard

Co-founded the pharmaceutical firm Pharmstandard with Roman Abramovich.

2008

Pharmstandard IPO

Successfully listed Pharmstandard on the London Stock Exchange.

2016

Privatization of Pharmstandard

Brought Pharmstandard back into private hands.

2021

Acquired TSS group

Acquired TSS group, an equipment manufacturing firm, through Augment Investments.

Philanthropy & Social Impact

Healthcare

Healthcare Initiatives

Undisclosed

Funding programs to address health issues and support healthcare infrastructure development.

Education

Educational Initiatives

Undisclosed

Supporting educational institutions and initiatives that promote scientific research and innovation.

Controversies & Challenges

2022

Allegations of Sanction Evasion

Relocated his firm Augment Investments from Cyprus to Oktyabrsky Island, allegedly to avoid sanctions related to the Russian invasion of Ukraine.

Ongoing

Involvement in Corruption Schemes

Pharmaceutical companies owned by Kharitonin are implicated in corruption schemes organized by Russian government officials.